Epi - L2 - Interventional Studies Flashcards
What other terms could be used or “interventional studies”
clinical trial, clinical study, experimental study, human study, investigational study
what are the key differences between interventional studies and observational studies?
- investigator selects “interventions” and allocates study subjects to forced-intervention groups
- more ‘rigorous’ in its ability to show cause-and-effect
- can demonstrate causation
What are the phases of interventional studies?
phase 0, 1, 2, 3, 4
what are the differentiating factors as the phases progress?
- purpose/ focus of the study
- population studies (healthy/ diseased)
- sample size
- duration
what occurs before phase 0?
Pre-Clinical:
- bench research; animal research.
- research prior-to human investigation
Phase 0
aka Exploratory; Investigational New Drug
- Assess drug-target actions and possibly pharmacokinetics in single or ‘a few’ doses (FIRST-IN-HUMAN USE) **does it or does it not DO what we EXPECT it to do based on pre-clinical stage)
- Healthy (or diseased patients ) volunteers
- Very small N (eg: <20)
- Very short duration (eg: a single dose to just a few days)
YOU DO NOT SEE SAFETY OR EFFICACY
Exam Freebie:
Phase 0 and Phase 1 are the only ones you can see healthy patients in // Phase 4 = NEVER use healthy people
Phase 1
aka Investigational New Drug
- assess SAFETY/ TOLERANCE and pharmacokinetics of one or more dosages (first-in-human/ early-in-human use)
- Healthy or Disease volunteers (depends on disease)
- Small N (eg: 20-80)
- Short duration (eg: just a few weeks)
*classic sign: SAFETY and PHARMACOKINETICS for the first time here –> how does the body handle the drug?
Phase 2
aka Investigational New Drug
classic sign: EFFICACY of drug; dose escalation: different groups with different doses to see who has best results
- assess effectiveness (continue to assess safety/tolerability; expands on Phase 1 purpose)
- Diseased volunteers
- may have narrow inclusion criteria for isolation of effects - Larger N (100-300)
- short- to-medium duration (weeks to months)
Phase 3
(Investigational New Drug; Indication/ Population)
classic detail: P3 is the last phase before FDA approval
- Assess effectivness
- Diseased volunteers
- may expand inclusion and comparison groups for delineation of effects
- various statistical-perspectives can be taken in studies: superiority; noninferiority; equivalency - Larger N (500-3000)
- Longer duration (few months to a year+)
Phase 4
aka post FDA-Approval
- assess long-term safety, effectiveness, optimal use (risk/ benefits)
- diseased volunteers (expand use criteria
what are the advantages of Interventional trials?
- cause precedes effects, can demonstrate causation
- only designs used by FDA for “approval” process (on-label)
what are some disadvantages of Interventional Trials?
- cost
- complexity/ time
- ethical considerations (risk vs benefit evaluation)
- generalizability (aka; external validity) - is study pop similar to general population and will methodology and findings be applicable to them?
what are the terms explaining how many RANDOMIZATION steps must the enrolled participant go through before they’re in the final group?
- simple
- factorial
all studies can either be:
simple or factorial;
and
parallel or series